Inventor · disambiguated record
Maria Cristina Geroni
Also filed as: GERONI MARIA C · GERONI MARIA CRISTINA · GERONI MARIA CRISTINA ROSA
13 granted patents·8 pending applications·81 citations·filing 1995–2009
89Inventor score
Files withPHARMACIA ITALIA SPA7NERVIANO MEDICAL SCIENCES SRL6PHARMACIA & UPJOHN SPA3ERBA CARLO SPA1GERONI MARIA C1
Top patents by PatentIndex Score
21 records- 0191US6586428B2Combined preparations comprising morpholine anthracyclines and anticancer agentPHARMACIA ITALIA SPA·Filed 2002·Granted Jul 1, 2003·40 cites·22 claims
- 0273US6838547B2Glutathiaone conjugates with distamycin derivatives having antitumoral activityPHARMACIA ITALIA SPA·Filed 2001·Granted Jan 4, 2005·3 cites·13 claims
- 0373US6576612B1Antitumor therapy comprising distamycin derivativesPHARMACIA ITALIA SPA·Filed 2000·Granted Jun 10, 2003·11 cites·13 claims
- 0470US6177408B1Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agentsPHARMACIA & UPJOHN SPA·Filed 1997·Granted Jan 23, 2001·14 cites·6 claims
- 0569US7642229B2Pharmaceutical composition and a product which includes a substituted acryloyl distamycin derivative, an antimicrotubule agent and/or an antimetaboliteNERVIANO MEDICAL SCIENCES SRL·Filed 2001·Granted Jan 5, 2010·1 cites·9 claims
- 0667US7030089B2Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathionePHARMACIA ITALIA SPA·Filed 2001·Granted Apr 18, 2006·3 cites·16 claims
- 0761US8940334B2Pharmaceutical composition of an anthracyclineGERONI MARIA CRISTINA·Filed 2008·Granted Jan 27, 2015·2 cites·2 claims
- 0857US7399748B2Antitumor therapy comprising distamycin derivativesNERVIANO MEDICAL SCIENCES SRL·Filed 2001·Granted Jul 15, 2008·1 cites·2 claims
- 0957US2007249651A1Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2007·Application pending·0 cites
- 1050US2011021517A1Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agentsNERVIANO MEDICAL SCIENCES SRL·Filed 2009·Application pending·0 cites
- 1148US6537990B1Combined preparations comprising morpholine anthracyclines and anticancer agentPHARMACIA ITALIA SPA·Filed 2000·Granted Mar 25, 2003·0 cites·15 claims
- 1247US2010104566A1Antitumor combination comprising a morpholinyl anthracycline and an antibodyNERVIANO MEDICAL SCIENCES SRL·Filed 2008·Application pending·0 cites
- 1347US2011166077A9Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapyPHARMACIA ITALIA SPA·Filed 2004·Application pending·0 cites
- 1443US2009074757A1Antitumor Combination Comprising Substituted Acryloyl Distamycin Derivatives and Antibodies Inhibiting Growth Factors or Their ReceptorsPESENTI ENRICO·Filed 2006·Application pending·0 cites
- 1541US2010190736A1Morpholinyl anthracycline derivative combined with protein kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2008·Application pending·0 cites
- 1640US5596105ATherapeutically active naphthalenesulfonic pyrrolecarboxamido derivativesERBA CARLO SPA·Filed 1995·Granted Jan 21, 1997·4 cites·2 claims
- 1739US2003162722A1Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase I and II inhibitorsFiled 2001·Application pending·0 cites
- 1837US2006084612A1Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitorsGERONI MARIA C·Filed 2002·Application pending·0 cites
- 1936US6165980ADistamycin derivatives, process for preparing them, and their use as antitumor and antiviral agentsPHARMACIA & UPJOHN SPA·Filed 1997·Granted Dec 26, 2000·2 cites·15 claims
- 2031US6258786B113-dihydro-3′ aziridino anthracyclinesPHARMACIA & UPJOHN SPA·Filed 1999·Granted Jul 10, 2001·0 cites·10 claims
- 2127US6596845B1Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA ITALIA SPA·Filed 1999·Granted Jul 22, 2003·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →